You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 169 No. 10, May 25, 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Breast Cancer
 •Women's Health
 •Women's Health, Other
 •Screening
 •Mammography
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Hormone Therapy Use May Explain Recent Results Regarding Tumor Regression

Harald Weedon-Fekjær, PhD; Ragnhild Sørum, MSc; Marianne Kolstad Brenn, MSc

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In their article, Zahl et al1 suggest that many breast cancer tumors detected during mammographic screening discontinue their detectability thereafter and may spontaneously regress. They used ecological data to compare 2 different cohorts over 2 different calendar periods, reporting a relative rate of invasive breast cancer of 1.22 (95% confidence interval [CI]; 1.16-1.30) in women who had the opportunity to undergo 3 vs 1 screening examinations. The study, while novel in its design, unfortunately has substantial weaknesses.

The major concern with this result and the subsequent conclusion stems from a time-related differential in HT use in the 2 study cohorts (Figure). Breast cancer incidence has been shown to increase with HT use and is dependent on the estrogen-progesterone composition.2 Zahl et al1 performed a sensitivity analysis based on a study from the United States that reported a 24% . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

The Natural History of Invasive Breast Cancers Detected by Screening Mammography
Per-Henrik Zahl, Jan Mæhlen, and H. Gilbert Welch
Arch Intern Med. 2008;168(21):2311-2316.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.